March 30, 2026

The March 2026 News from ECOG-ACRIN blog is now available

March 24, 2026

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

February 27, 2026

The February 2026 News from ECOG-ACRIN blog is now available

February 13, 2026

The Winter 2026 advocacy blog Considering Clinical Trials is now available

February 9, 2026

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

January 31, 2026

The January 2026 News from ECOG-ACRIN blog is now available

January 29, 2026

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

January 21, 2026

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

ECOG-ACRIN Cancer Research Group